APOL1 at the Plasma Membrane and Cytotoxicity
About this episode
Dr. Oyindamola Christiana Adebayo discusses her study on Apolipoprotein L1 risk variants and their effects on cytotoxicity.
Dr. Oyindamola Christiana Adebayo discusses the results of her study, "Expression of Apolipoprotein L1 Risk Variants at the Plasma Membrane and Haplotype-Dependent Cytotoxicity," on behalf of her coauthors, with JASN Deputy Editor David H. Ellison.
More episodes of Journal of the American Society of Nephrology (JASN)
- Barriers to Kidney Transplantation in the United States
- ASN Kidney Translation Series: ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome
- ASN Kidney Translation Series: Cardiovascular-Kidney-Metabolic (CKM) Syndrome Advances
- Temporal, Cell-Specific Angiopoietin-2 in CKD
- Cardiovascular Effects of GLP-1 RA in Kidney Failure
- ASN Kidney Translation Series: Artificial Intelligence in Nephrology
Explore listener stats, chart rankings, contacts and more on the Journal of the American Society of Nephrology (JASN) podcast page.